These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6267958)

  • 1. Succinylcholine neuromuscular blockade in subjects heterozygous for abnormal plasma cholinesterase.
    Viby-Mogensen J
    Anesthesiology; 1981 Sep; 55(3):231-5. PubMed ID: 6267958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of bambuterol on plasma cholinesterase activity and suxamethonium-induced neuromuscular blockade in subjects heterozygous for abnormal plasma cholinesterase.
    Bang U; Viby-Mogensen J; Wirén JE
    Acta Anaesthesiol Scand; 1990 Oct; 34(7):600-4. PubMed ID: 2244450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment with pancuronium before suxamethonium administration in patients heterozygous for the usual and the atypical plasma cholinesterase gene.
    Ostergaard D; Viby-Mogensen J; Hanel HK; Skovgaard LT
    Acta Anaesthesiol Scand; 1991 Aug; 35(6):502-7. PubMed ID: 1897345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reaction to succinylcholine in two patients segregating for the plasma cholinesterase allele Ek.
    Jensen FS; Viby-Mogensen J
    Acta Anaesthesiol Scand; 1992 Nov; 36(8):753-7. PubMed ID: 1334612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mivacurium-induced neuromuscular blockade in patients with atypical plasma cholinesterase.
    Ostergaard D; Jensen FS; Jensen E; Skovgaard LT; Viby-Mogensen J
    Acta Anaesthesiol Scand; 1993 Apr; 37(3):314-8. PubMed ID: 8390770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma cholinesterase and abnormal reaction to succinylcholine: twenty years' experience with the Danish Cholinesterase Research Unit.
    Jensen FS; Viby-Mogensen J
    Acta Anaesthesiol Scand; 1995 Feb; 39(2):150-6. PubMed ID: 7793179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical importance of plasma cholinesterase for the anaesthetist.
    Pedersen NA; Jensen FS
    Ann Acad Med Singap; 1994 Nov; 23(6 Suppl):120-4. PubMed ID: 7710221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased sensitivity to succinylcholine in a patient heterozygous for the silent and the fluoride-resistant gene.
    Viby-Mogensen J; Hanel HK
    Anesth Analg; 1978; 57(4):422-7. PubMed ID: 568403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shortened action of succinylcholine in individuals with cholinesterase C5 isozyme.
    Sugimori T
    Can Anaesth Soc J; 1986 May; 33(3 Pt 1):321-7. PubMed ID: 3719432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of atracurium and succinylcholine for electroconvulsive therapy in a patient with atypical plasma cholinesterase.
    Hickey DR; O'Connor JP; Donati F
    Can J Anaesth; 1987 May; 34(3 ( Pt 1)):280-3. PubMed ID: 3581397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Train-of-four nerve stimulation in the management of prolonged neuromuscular blockade following succinylcholine.
    Savarese JJ; Ali HH; Murphy JD; Padget C; Lee CM; Ponitz J
    Anesthesiology; 1975 Jan; 42(1):106-11. PubMed ID: 122883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Succinylcholine apnoea: attempted reversal with anticholinesterases.
    Bevan DR; Donati F
    Can Anaesth Soc J; 1983 Sep; 30(5):536-9. PubMed ID: 6627074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of bambuterol (carbamylated terbutaline) on plasma cholinesterase activity and suxamethonium-induced neuromuscular blockade in genotypically normal patients.
    Bang U; Viby-Mogensen J; Wirén JE; Skovgaard LT
    Acta Anaesthesiol Scand; 1990 Oct; 34(7):596-9. PubMed ID: 2244449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of plasma cholinesterase activity and duration of action of succinylcholine during pregnancy.
    Blitt CD; Petty WC; Alberternst EE; Wright BJ
    Anesth Analg; 1977; 56(1):78-83. PubMed ID: 556913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics of long-term succinylcholine neuromuscular blockade during balanced anesthesia.
    Ramsey FM; Lebowitz PW; Savarese JJ; Ali HH
    Anesth Analg; 1980 Feb; 59(2):110-6. PubMed ID: 7189331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged apnoea after suxamethonium: an analysis of the first 225 cases reported to the Danish Cholinesterase Research Unit.
    Viby-Mogensen J; Hanel HK
    Acta Anaesthesiol Scand; 1978; 22(4):371-80. PubMed ID: 726855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plasma cholinesterase and abnormal reaction to suxamethonium injection. 20-year experience with the Danish Cholinesterase Registry].
    Jensen FS; Mogensen JV
    Ugeskr Laeger; 1996 Mar; 158(13):1835-9. PubMed ID: 8650760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketamine enhances phase I and phase II neuromuscular block of succinylcholine.
    Tsai SK; Lee CM; Tran B
    Can J Anaesth; 1989 Mar; 36(2):120-3. PubMed ID: 2706708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of enflurane and fentanyl on the clinical characteristics of long-term succinylcholine infusion.
    Donati F; Bevan DR
    Can Anaesth Soc J; 1982 Jan; 29(1):59-64. PubMed ID: 6275972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium carbonate and neuromuscular blocking agents.
    Hill GE; Wong KC; Hodges MR
    Anesthesiology; 1977 Feb; 46(2):122-6. PubMed ID: 835845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.